Endologix Completes $54 Million Acquisition of Nellix, Inc.

Represented Endologix, Inc. in its acquisition of Nellix, Inc., up to $54 million. Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms.